ACADIAN ASSET MANAGEMENT LLC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 17 filers reported holding ATYR PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q4 2022$57
-99.9%
26,419
+32.3%
0.00%
Q2 2022$57,000
-72.6%
19,963
-53.3%
0.00%
-100.0%
Q2 2021$208,000
-54.5%
42,724
-58.4%
0.00%
-50.0%
Q1 2021$457,000
+41.9%
102,697
+23.7%
0.00%
+100.0%
Q4 2020$322,000
+19.7%
83,0520.0%0.00%0.0%
Q3 2020$269,000
-10.9%
83,052
+22.2%
0.00%0.0%
Q2 2020$302,000
+182.2%
67,964
+122.3%
0.00%
Q3 2019$107,00030,5760.00%
Other shareholders
ATYR PHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 624,000$1,3672.16%
Tikvah Management LLC 1,350,833$2,958,3241.41%
VR Adviser, LLC 1,171,436$2,565,4450.43%
TANG CAPITAL MANAGEMENT LLC 123,430$270,3120.04%
FEDERATED HERMES, INC. 5,231,600$11,457,2040.03%
Alyeska Investment Group, L.P. 1,378,747$3,019,4560.03%
Walleye Capital LLC 750,000$1,642,5000.03%
Tower Research Capital LLC (TRC) 17,443$380.00%
CITIGROUP INC 428,460$938,3270.00%
PFS Partners, LLC 406$8900.00%
View complete list of ATYR PHARMA INC shareholders